Lowtrade, AMBS just announced major increase in issuable shares as they merged and incorporated into Nevada rather Delaware. Any thoughts on dark side play for a company such as AMBS issues an additional 117,790,239 shares? I know we will know more when 10k is filed, but at this point it could be two weeks before the filing.
Potential thoughts:
1. Joint Venture
2. Dilution - to it's purist form (not likely)
3. Acquisition
4. Funny Money
5. ????
Major transfer of funding through stock rather loan financing is about to occur...
From 8-k:
A. Amarantus Delaware was incorporated in 2008 as Jumpkicks, Inc., changed its name to Amarantus Biosciences, Inc. in June 2011, and changed its name to Amarantus Bioscience, Inc. on 27 November 2012. Its current authorized capital stock consists of: (1) 1,000,000,000 shares of Common Stock, par value $0.001 (“Amarantus Bioscience, Inc. Delaware Common Stock”), of which 367,790,239 shares are issued and outstanding; and (2) 10,000,000 shares of Preferred Stock, par value $0.001 (“Amarantus Bioscience, Inc. Delaware Preferred Stock”), of which 250,000 shares are issued and outstanding.
B. Amarantus Nevada was incorporated on March 22, 2013. Its authorized capital stock consists of: (1) 1,000,000,000 shares of Common Stock, with a par value of $0.001 per share (“Amarantus Bioscience, Inc. Nevada Common Stock”), of which, pursuant to the terms of this Agreement and Plan of Merger, 367,790,139 shares will be issued and outstanding at the Effective Time (as defined below); and (2) 10,000,000 shares of Preferred Stock, $0.001 par value (“Amarantus Bioscience, Inc. Nevada Preferred Stock”), of which, pursuant to the terms of this Agreement and Plan of Merger, 250,000 shares are issued and outstanding at the Effective Time.
AI
